Radiopharmaceutical quality control

Kits are currently available for the preparation of technetium-labeled compounds for scanning the lungs, liver, kidneys, and skeleton. Prior to administration of these radiopharmaceuticals to the patient, adequate quality control should be performed. The phenomenal growth in the diagnostic use of radiopharmaceuticals has shifted much of the manufacture and quality control to the individual nuclear medicine laboratory. This quality control encompasses chemical, biological, and radioactivity analysis. Considerations and test methods are detailed within this review.